BJL
CMPX icon

Brighton Jones LLC’s Compass Therapeutics CMPX Stock Holding History

Brighton Jones LLC’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.1K Buy
+18,317
New +$54.1K ﹤0.01% 1374

Other funds holding CMPX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brighton Jones LLC's CMPX Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in Compass Therapeutics (CMPX) in Q2 2026: 18,317 shares worth $40.1K. The stake represents ﹤0.01% of the portfolio and ranks #1374 among its holdings.

83 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Brighton Jones LLC held 18,317 shares of Compass Therapeutics worth $40.1K as of Q2 2026.
  • Compass Therapeutics was a new Brighton Jones LLC position in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1374 holding.
  • 83 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.